KEMET Reports Third Quarter of Fiscal Year 2012 Results
GREENVILLE, S.C., Feb. 2, 2012 /PRNewswire/ -- KEMET Corporation ("KEMET" or the "Company") (NYSE: KEM) today reported preliminary results for the third fiscal quarter ended December 31, 2011. Net sales for the quarter ended December 31, 2011 were $218.8 million which is a 17.3% decrease over the same quarter last fiscal year. Net sales for the nine months ended December 31, 2011 were $774.2 million which is a 2.3% increase over the same period last fiscal year.
On a U.S. GAAP basis, net loss was $(27.8) million, or $(0.62) per basic and diluted share for the third quarter of fiscal year 2012 compared to net income of $27.2 million or $0.52 per diluted share for the same quarter last year.
Non-GAAP adjusted net income was $2.0 million or $0.04 per diluted share for the third quarter of fiscal year 2012 compared to $33.1 million of adjusted net income or $0.64 per diluted share for the same quarter last year.
"We entered this quarter knowing that the impact of the distribution channel inventory rebalancing would have a significant impact on our financial results", said Per Loof, Chief Executive Officer of KEMET. "However, we generated approximately $21 million of cash from operations and we were successful in securing one of our key supply sources through the acquisition of Niotan Incorporated. Even though we expect the next couple of quarters to remain challenging we are positioning the Company for a strong rebound through our continuing realignment of facilities in Europe and supply chain integration when the world economy improves," continued Loof.
On a U.S. GAAP basis, the third quarter of fiscal year 2012 includes a $15.8 million impairment charge related to the Tantalum Business Group. In addition, the third quarter of fiscal year 2012 includes $10.7 million of restructuring charges primarily comprised of termination benefits of $6.1 million related to planned facility closures in Italy that will commence during fiscal year 2013 and charges of $4.5 million to participate in a plan to save labor costs whereby a company may temporarily "lay off" employees while the government continues to pay their wages for a certain period of time. This restructuring activity is a continuation of the Company's efforts to restructure its manufacturing operations within Europe, primarily within the Film and Electrolytic segment. Construction has started on a new manufacturing facility in Pontecchio, Italy, that will allow the closure and consolidation of three manufacturing operations located in Italy. The third quarter of fiscal year 2011 included $1.1 million of restructuring charges primarily associated with the relocation of equipment and $1.0 million of debt and stock registration related fees.
About KEMET
The Company's common stock is listed on the NYSE under the ticker symbol "KEM" (NYSE: KEM). At the Investor Relations section of our web site at http://ir.kemet.com, users may subscribe to KEMET news releases and find additional information about our Company. KEMET applies world class service and quality to deliver industry leading, high performance capacitance solutions to its customers around the world and offers the world's most complete line of surface mount and through hole capacitor technologies across tantalum, ceramic, film, aluminum, electrolytic, and paper dielectrics. Additional information about KEMET can be found at http://www.kemet.com.
QUIET PERIOD
Beginning April 1, 2012, we will observe a quiet period during which the information provided in this news release and our quarterly report on Form 10-Q will no longer constitute our current expectations. During the quiet period, this information should be considered to be historical, applying prior to the quiet period only and not subject to update by management. The quiet period will extend until the day when our next quarterly earnings release is published.
CAUTIONARY STATEMENT ON FORWARD-LOOKING STATEMENTS
Certain statements included herein contain forward-looking statements within the meaning of federal securities laws about KEMET Corporation's (the "Company") financial condition and results of operations that are based on management's current expectations, estimates and projections about the markets, in which the Company operates, as well as management's beliefs and assumptions. Words such as "expects," "anticipates," "believes," "estimates," variations of such words and other similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and involve certain risks, uncertainties and assumptions, which are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in, or implied by, such forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management's judgment only as of the date hereof. The Company undertakes no obligation to update publicly any of these forward-looking statements to reflect new information, future events or otherwise.
Factors that may cause actual outcome and results to differ materially from those expressed in, or implied by, these forward-looking statements include, but are not necessarily limited to the following:
(i) adverse economic conditions could impact our ability to realize operating plans if the demand for our products declines, and such conditions could adversely affect our liquidity and ability to continue to operate; (ii) adverse economic conditions could cause the write down of long-lived assets; (iii) an increase in the cost or a decrease in the availability of our principal raw materials; (iv) changes in the competitive environment; (v) uncertainty of the timing of customer product qualifications in heavily regulated industries; (vi) economic, political, or regulatory changes in the countries in which we operate; (vii) difficulties, delays or unexpected costs in completing the restructuring plan; (viii) inability to attract, train and retain effective employees and management; (ix) inability to develop innovative products to maintain customer relationships and offset potential price erosion in older products; (x) exposure to claims alleging product defects; (xi) the impact of laws and regulations that apply to our business, including those relating to environmental matters; (xii) volatility of financial and credit markets affecting our access to capital; (xiii) needing to reduce the total costs of our products to remain competitive; (xiv) potential limitation on the use of net operating losses to offset possible future taxable income; (xv) restrictions in our debt agreements that limit our flexibility in operating our business; and (xvi) additional exercise of the warrant by K Equity which could potentially result in the existence of a significant stockholder who could seek to influence our corporate decisions.
Contact:
Dean W. Dimke
Director of Corporate and
Investor Communications
954-766-2800
William M. Lowe, Jr.
Executive Vice President and
Chief Financial Officer
864-963-6484
KEMET CORPORATION AND SUBSIDIARIES
Condensed Consolidated Statements of Operations
(Amounts in thousands except per share data)
(Unaudited)
Quarters Ended December 31, Nine Months Ended December 31,
--------------------------- ------------------------------
2011 2010 2011 2010
---- ---- ---- ----
Net sales $218,795 $264,654 $774,165 $757,036
Operating costs
and expenses:
Cost of sales 178,305 192,132 592,128 553,888
Selling, general
and
administrative
expenses 24,737 27,453 83,368 76,667
Research and
development 7,172 6,947 21,620 19,202
Restructuring
charges 10,748 1,102 13,378 5,197
Write down of
long-lived
assets 15,786 - 15,786 -
Net (gain) loss on
sales and
disposals of
assets 9 29 92 (1,406)
Total operating
costs and
expenses 236,757 227,663 726,372 653,548
------- ------- ------- -------
Operating income
(loss) (17,962) 36,991 47,793 103,488
Other (income)
expense:
Interest income (62) (28) (136) (133)
Interest expense 7,036 7,756 21,718 22,548
Other (income)
expense, net 716 1,471 1,918 (1,647)
Loss on early
extinguishment of
debt - - - 38,248
--- --- --- ------
Income (loss)
before income
taxes (25,652) 27,792 24,293 44,472
Income tax expense 2,119 625 5,897 2,493
Net income (loss) $(27,771) $27,167 $18,396 $41,979
======== ======= ======= =======
Net income (loss)
per share:
Basic $(0.62) $0.96 $0.43 $1.53
Diluted $(0.62) $0.52 $0.35 $0.82
Weighted-average
shares
outstanding:
Basic 44,644 28,295 42,834 27,464
Diluted 44,644 51,960 52,302 51,124
KEMET CORPORATION AND SUBSIDIARIES
Condensed Consolidated Balance Sheets
(Amounts in thousands, except per share data)
December 31, March 31,
2011 2011
------------- ----------
ASSETS (Unaudited)
Current assets:
Cash and cash equivalents $136,049 $152,051
Accounts receivable, net 102,432 150,370
Inventories, net 212,118 206,440
Prepaid expenses and other 23,536 28,097
Deferred income taxes 4,027 5,301
----- -----
Total current assets 478,162 542,259
Property and equipment, net of
accumulated depreciation of
$770,259
and $740,773 as of December 31,
2011 and March 31, 2011,
respectively 290,045 310,412
Goodwill and intangible assets, net 20,479 20,092
Other assets 12,993 11,546
Total assets $801,679 $884,309
======== ========
LIABILITIES AND STOCKHOLDERS'
EQUITY
Current liabilities:
Current portion of long-term debt $1,219 $42,101
Accounts payable 71,072 90,997
Accrued expenses 65,073 88,291
Income taxes payable 4,239 4,265
----- -----
Total current liabilities 141,603 225,654
Long-term debt, less current
portion 229,847 231,215
Other non-current obligations 58,113 59,727
Deferred income taxes 6,894 7,960
- -
Stockholders' equity:
Preferred stock, par value $0.01,
authorized 10,000 shares, none
issued - -
Common stock, par value $0.01,
authorized 175,000 and 300,000
shares, issued
46,508 and 39,508 shares, at
December 31, 2011 and March 31,
2011, respectively 465 395
Additional paid-in capital 468,646 479,322
Retained deficit (69,349) (87,745)
Accumulated other comprehensive
income 8,305 22,555
Treasury stock, at cost (1,854 and
2,370 shares at December 31, 2011
and
March 31, 2011, respectively) (42,845) (54,774)
Total stockholders' equity 365,222 359,753
------- -------
- -
Total liabilities and stockholders'
equity $801,679 $884,309
======== ========
KEMET CORPORATION AND SUBSIDIARIES
Condensed Consolidated Statements of Cash Flows
(Amounts in thousands)
(Unaudited)
Nine Months Ended December 31,
------------------------------
2011 2010
---- ----
Sources (uses) of cash
and cash equivalents
Operating activities:
Net income $18,396 $41,979
Adjustments to reconcile
net income to net cash
provided by
operating activities:
Depreciation and
amortization 33,384 41,303
Write down of long-
lived assets 15,786 -
Amortization of debt
discount and debt
issuance costs 2,903 3,964
Net (gain) loss on sales
and disposals of assets 92 (1,406)
Stock-based
compensation expense 1,378 911
Change in deferred
income taxes 909 (1,186)
Change in operating
assets 46,330 (64,485)
Change in operating
liabilities (48,116) 17,658
Other 841 (1,885)
Loss on early
extinguishment of debt - 38,248
Net cash provided by
operating activities 71,903 75,101
------ ------
Investing activities:
Capital expenditures (31,793) (19,559)
Acquisition, net of cash
received (11,584) -
Proceeds from sales of
assets - 5,425
Net cash used in
investing activities (43,377) (14,134)
------- -------
Financing activities:
Proceeds from issuance
of debt - 227,525
Payments of long-term
debt (40,581) (230,300)
Net payments under other
credit facilities (3,153) (2,626)
Proceeds from exercise
of stock options 225 21
Debt issuance costs (36) (7,750)
Debt extinguishment
costs - (207)
Net cash used in
financing activities (43,545) (13,337)
------- -------
Net increase (decrease) in cash
and cash equivalents (15,019) 47,630
Effect of foreign
currency fluctuations
on cash (983) 943
Cash and cash
equivalents at
beginning of fiscal
period 152,051 79,199
Cash and cash
equivalents at end of
fiscal period $136,049 $127,772
======== ========
Non-U.S. GAAP Financial Measures
In this news release, the Company makes reference to certain Non-U.S. GAAP financial measures, including "Adjusted net income", "Adjusted net income per share" and "Adjusted EBITDA". Management believes that investors may find it useful to review the Company's financial results as adjusted to exclude items as determined by management.
Adjusted Net Income and Adjusted Net Income Per Share
"Adjusted net income" and "Adjusted net income per share" represent net income and net income per share excluding write down of long-lived assets, restructuring charges related primarily to equipment moves and employee severance, plant start-up costs, amortization related to debt issuance costs and debt discount, net gain/loss on sales and disposals of assets, ERP integration costs, stock-based compensation expense/recovery, net foreign exchange loss, registration related fees, acquisition related fees, gain on licensing of patents, loss on early extinguishment of debt, income tax expense related to foreign tax law changes which limit the utilization of net operating losses, and income tax effect on non-GAAP adjustments. Management believes that these Non-U.S. GAAP financial measures are useful to investors because they provide a supplemental way to understand the underlying operating performance of the Company. Management uses these Non-U.S. GAAP financial measures to evaluate operating performance. Non-U.S. GAAP financial measures should not be considered as an alternative to net income, operating income or any other performance measures derived in accordance with U.S. GAAP.
The following table provides reconciliation from U.S. GAAP net income (loss) to Non-U.S. GAAP adjusted net income:
GAAP to Non-GAAP Reconciliation
Nine Months Ended
Quarters Ended December 31,
-------------- -----------------
December 31, September 30, December 31,
2011 2011 2010 2011 2010
------------- -------------- ------------- ---- ----
(Unaudited) (Amounts in thousands, except per share data)
Net sales $218,795 $265,514 $264,654 $774,165 $757,036
Net income (loss) $(27,771) $14,318 $27,167 $18,396 $41,979
Basic net income (loss)
per share $(0.62) $0.32 $0.96 $0.43 $1.53
Diluted net income (loss)
per share $(0.62) $0.27 $0.52 $0.35 $0.82
Excluding the following
items (Non-GAAP)
Net income (loss) $(27,771) $14,318 $27,167 $18,396 $41,979
Adjustments:
Write down of long-lived
assets 15,786 - - 15,786 -
Restructuring charges 10,748 1,605 1,102 13,378 5,197
Plant start-up costs 666 718 - 1,384 -
Amortization included in
interest expense 847 1,012 1,210 2,903 3,964
Net (gain) loss on sales
and disposals of assets 9 (40) 29 92 (1,406)
ERP integration costs 1,812 1,918 602 4,935 1,257
Stock-based compensation
expense (recovery) (797) 984 429 1,378 911
Net foreign exchange loss 303 1,391 1,785 1,571 378
Registration related fees - 77 950 281 950
Acquisition related fees - - - 610 -
Gain on licensing of
patents - - - - (2,000)
Loss on early
extinguishment of debt - - - - 38,248
Income tax expense
related to foreign tax
law changes 1,448 - - 1,448 -
Income tax effect of non-
GAAP adjustments (1) (1,050) 406 (196) (660) (828)
------ --- ---- ---- ----
Adjusted net income $2,001 $22,389 $33,078 $61,502 $88,650
====== ======= ======= ======= =======
Adjusted net income per
share (excluding
adjustments):
Basic $0.04 $0.50 $1.17 $1.44 $3.23
Diluted $0.04 $0.43 $0.64 $1.18 $1.73
Weighted-average shares
outstanding:
Basic 44,644 44,370 28,295 42,834 27,464
Diluted 52,209 52,230 51,960 52,302 51,124
(1) The income tax effect of the excluded items is calculated by applying the applicable
jurisdictional income tax rate, considering the deferred tax valuation for each applicable
jurisdiction.
Adjusted EBITDA
Adjusted EBITDA represents net income (loss) before income tax expense, net interest expense, and depreciation and amortization expense, adjusted to exclude: write down of long-lived assets, restructuring charges, plant start-up costs, net foreign exchange loss, stock-based compensation expense/recovery, gain/loss on sales and disposals of assets, ERP integration costs, registration related fees, acquisition related fees, gain on licensing of patents, and loss on early extinguishment of debt. We use Adjusted EBITDA to monitor and evaluate our operating performance and to facilitate internal and external comparisons of the historical operating performance of our business. We present Adjusted EBITDA as a supplemental measure of our performance and ability to service debt. We also present Adjusted EBITDA because we believe such measure is frequently used by securities analysts, investors and other interested parties in the evaluation of companies in our industry.
We believe Adjusted EBITDA is an appropriate supplemental measure of debt service capacity, because cash expenditures on interest are, by definition, available to pay interest, and tax expense is inversely correlated to interest expense because tax expense goes down as deductible interest expense goes up; depreciation and amortization are non-cash charges. The other items excluded from Adjusted EBITDA are excluded in order to better reflect our continuing operations.
In evaluating Adjusted EBITDA, you should be aware that in the future we may incur expenses similar to the adjustments noted below. Our presentation of Adjusted EBITDA should not be construed as an inference that our future results will be unaffected by these types of adjustments. Adjusted EBITDA is not a measurement of our financial performance under U.S. GAAP and should not be considered as an alternative to net income, operating income or any other performance measures derived in accordance with U.S. GAAP or as an alternative to cash flow from operating activities as a measure of our liquidity.
Our Adjusted EBITDA measure has limitations as an analytical tool, and you should not consider it in isolation or as a substitute for analysis of our results as reported under U.S. GAAP. Some of these limitations are:
-- it does not reflect our cash expenditures, future requirements for
capital expenditures or contractual commitments;
-- it does not reflect changes in, or cash requirements for, our working
capital needs;
-- it does not reflect the significant interest expense or the cash
requirements necessary to service interest or principal payment on our
debt;
-- although depreciation and amortization are non-cash charges, the assets
being depreciated and amortized will often have to be replaced in the
future, and our Adjusted EBITDA measure does not reflect any cash
requirements for such replacements;
-- it is not adjusted for all non-cash income or expense items that are
reflected in our statements of cash flows;
-- it does not reflect the impact of earnings or charges resulting from
matters we consider not to be indicative of our ongoing operations;
-- it does not reflect limitations on or costs related to transferring
earnings from our subsidiaries to us; and
-- other companies in our industry may calculate this measure differently
than we do, limiting its usefulness as a comparative measure.
Because of these limitations, Adjusted EBITDA should not be considered as a measure of discretionary cash available to us to invest in the growth of our business or as a measure of cash that will be available to us to meet our obligations. You should compensate for these limitations by relying primarily on our U.S. GAAP results and using Adjusted EBITDA only supplementally.
The following table provides a reconciliation from U.S. GAAP net income (loss) to Adjusted EBITDA (amounts in thousands):
Quarters Ended Nine Months Ended
December 31, December 31,
-------------- -----------------
2011 2010 2011 2010
---- ---- ---- ----
Net income (loss) $(27,771) $27,167 $18,396 $41,979
Adjustments:
Income tax expense 2,119 625 5,897 2,493
Interest expense, net 6,974 7,728 21,582 22,415
Depreciation and
amortization 10,373 12,661 33,384 41,303
Write down of long-
lived assets 15,786 - 15,786 -
Restructuring charges 10,748 1,102 13,378 5,197
Plant start-up costs 666 - 1,384 -
Net foreign exchange
loss 303 1,785 1,571 378
Stock-based
compensation expense
(recovery) (797) 429 1,378 911
Net (gain) loss on
sales and disposals of
assets 9 29 92 (1,406)
ERP integration costs 1,812 602 4,935 1,257
Registration related
fees - 950 281 950
Acquisition related
fees - - 610 -
Gain on licensing of
patents - - - (2,000)
Loss on early
extinguishment of debt - - - 38,248
--- --- --- ------
Adjusted EBITDA $20,222 $53,078 $118,674 $151,725
======= ======= ======== ========
SOURCE KEMET Corporation